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ABSTRACT
Minor histocompatibility antigens (mHags) can induce T-cell reactivities with important consequences for the
graft-versus-leukemia effect and the development of graft-versus-host disease in HLA-matched stem cell trans-
plantation settings. Recently, mHag-specific T cells were also demonstrated in multiparous woman and in solid
organ transplant recipients. Microchimeric cells have been detected in the latter settings. To study whether
microchimerism is instrumental in the induction and/or maintenance of mHag T cells, we developed an HA-1
allele–specific nested polymerase chain reaction. To optimize and validate the reliability of this method at different
levels of microchimerism, serial dilutions of HA-1H cells titrated into HA-1R cells were tested. We demonstrated
that the HA-1H allele can be reliably and consistently detected at concentrations as low as 1:105 without losing
specificity. The developed HA-1–specific nested polymerase chain reaction is an important tool that facilitates the
detection of HA-1 microchimerism in various clinical specimens and that promotes investigation of the effects of
microchimerism on induction of mHag-specific T cells in the various settings of immunization.
© 2005 American Society for Blood and Marrow Transplantation
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cNTRODUCTION
Minor histocompatibility antigens (mHags) are im-
unogenic peptides, derived from polymorphic self-
roteins, that are presented on the cell surface in the
ontext of HLAmolecules. In anHLA-matched, mHag-
ismatched transplantation setting, presentation of the
Hag by antigen-presenting cells can induce a pow-
rful T cell–mediated alloimmune response in vivo and
n vitro [1,2]. The mHag HA-1 consists of a nonameric
eptide with amino acid sequence VLHDDLLEA,
hich is presented in the context of HLA-A2 [3]. Its
llelic counterpart VLRDDLLEA is nonimmunogenic.
n the case of mHag HA-1 disparity, T cells derived
rom an HA-1R individual will recognize the HA-1H
eptide as foreign and mount an immune response.
vidence has been obtained for multiparity-induced
cells to paternal mHags [4,5]. Reciprocal primingeemed to occur as well. Namely, umbilical cord blood c
B&MTontains cytotoxic T cells speciﬁc for maternal minor
ntigens [6]. Recently, we demonstrated circulating
A-1–speciﬁc T-regulatory and T-cytotoxic cells in a
enal transplant patient [7]. It is interesting to note
hat in both the solid organ recipient and the multip-
rous women, HA-1 microchimerism was detected.
o study the role and causal relationship between
icrochimerism and the induction and maintenance
f mHag-speciﬁc T cells, we developed a sensitive
echnique to detect low numbers of HA-1H and
A-1R chimeric cells.
ATERIALS AND METHODS
ell Culture and Isolation of Genomic DNA
Epstein-Barr virus–transformed B-lymphoblastoid
ell lines (EBV-BLCL) were cultured in RPMI-1640
ontaining 3 mmol/L l-glutamine and 10% fetal calf
345
s
w
d
U
t
p
l
i
ﬂ
d
f
d
M
t
a
g
f
p
c

B
e
p
ﬂ
B
P
N
t
G
r
A
p
s
1
K
a
a
A
c
2
w
5
w
u
t
s
w
b
c
c
a
r
a
3
1
E
e
R
D
o
u
R
H
r
p
t
m
1
t
s
n
d
t
s
t
s
t
i
c
m
c
t
s
S
H
F
p
T
S
F
R
F
F
R
B. Wieles et al.
3erum. Peripheral blood mononuclear cells (PBMCs)
ere isolated from buffy coats by Ficoll Hypaque
ensity gradient centrifugation (Pharmacia Biotech,
ppsala, Sweden). Informed consent was obtained for
he collection of material, and sample collection was
art of an approved protocol according to the guide-
ines of the local ethics committees. Cell subsets were
solated from the PBMC pool with a FACSVantage
ow cytometer (Becton Dickinson, San Jose, CA) as
escribed previously [7] by using CD3 for the T-cell
raction and CD19 for the B-cell fraction. The 2
endritic cell (DC) subsets were sorted by using the
iltenyi beads magnetic sorting system (Miltenyi Bio-
ech, Auburn, CA) with bead conjugated monoclonal
ntibodies directed against blood dendritic cell anti-
en (BDCA)-1 and BDCA-3 for DC1 and BDCA-2
or DC2. DC1 populations were judged to be 98%
ure as determined by CD11c expression by ﬂow
ytometry, and DC2 populations were found to be
92% pure as judged by the expression of CD123.
oth subsets were determined by gating on the lin-
age-negative (CD3, CD14, and CD19), HLA-DR
ositive population. Genomic DNA from PBMCs,
uorescence-activated cell-sorted fractions, and EBV-
LCLs was isolated with the High Pure Template
uriﬁcation Kit (Roche Diagnostics, Almere, The
etherlands) according to the manufacturer’s descrip-
ion. For each DNA isolation, 2 106 cells were used.
enomic Nested Polymerase Chain Reaction
For each ﬁrst non–allele-speciﬁc polymerase chain
eaction (PCR), 750 ng of genomic DNA was used.
mpliﬁcations were performed with 20 pmol of
rimer (see Table 1 for speciﬁc primers used in this
tudy) in 100 L of a reaction mixture containing
0 mmol/L Tris/HCl (pH 8.4) buffer, 50 mmol/L
Cl, 4 mmol/L MgCl2, 0.06 mg/mL bovine serum
lbumin, 0.5 mmol/L deoxynucleotide triphosphates,
nd 2.5 units of Taq polymerase (Roche Diagnostics,
lmere, The Netherlands). The ﬁrst non–allele-spe-
iﬁc PCR reaction started with a denaturation step of
minutes at 95°C. The cycling conditions, which
ere repeated 25 to 30 times, were 95°C for 1 minute,
8°C for 1 minute, and 72°C for 1 minute. The cycling
as followed by 72°C for 5minutes. The obtained prod-
ct with a size of 397 base pairs (bp) was diluted 100
able 1. Nucleotide Sequence of Primers Used in the HA-1 Allele–
peciﬁc Nested PCR
Primer Name Nucleotide Sequence
I 5=-GACGTCGTCGAGGACATCTCCCATC-3=
I 5=-GCATTCTCTGTTTCCGTGTT-3=
IIH 5=-CTTAAGGAGTGTGTGCTGCA-3=
IIR 5=-CTTAAGGAGTGTGTGTTGCG-3=
II 5=-CTGTGCATGGGACATTTCCT-3=imes, and 2 to 10 L of this dilution was used in the s
46econd PCR. The second allele-speciﬁc PCR started
ith a denaturation step of 2 minutes at 95°C followed
y 1 minute at 95°C and 1 minute at 72°C for 10
ycles. A second cycling step was performed (30 to 35
ycles) with the following cycling conditions: 1 minute
t 95°C, 1 minute at 69°C, and 1 minute at 72°C. The
eaction was ﬁnished with a 5-minute incubation step
t 72°C. A 10-L nested PCR product with a size of
04 bp was subjected to DNA electrophoresis on a
.5% agarose gel with the 100-bp DNA ladder (New
ngland Biolabs, Beverly, MA) for PCR fragment size
stimation.
ESULTS
evelopment of a Nested PCR for the Detection
f mHag HA-1 Microchimerism
A nested PCR was developed on genomic DNA by
sing 2 sets of primers. The ﬁrst primer set (FI and
I) ampliﬁes a part of the HA-1 gene surrounding the
A-1 immunogenic polymorphic T-cell epitope. The
esulting PCR fragment size is 397 bp. The second
rimer set (RII and FIIH or RII and FIIR) is used for
he allele-speciﬁc PCR and ampliﬁes a 304-bp frag-
ent of either the HA-1H–encoding gene or the HA-
R–encoding gene (Figure 1). The primers used in
his study are listed in Table 1.
An optimized PCR reaction should give high sen-
itivity and no background signals. Because the 20-
ucleotide-long allele-speciﬁc primers FIIH and FIIR
iffer in only 2 nucleotides, suboptimal PCR condi-
ions can lead to background signals. This background
ignal appears in the homozygous HA-1R samples with
he FIIH primer and/or in the homozygous HA-1H
amples with the FIIR primer. In the latter situation,
he PCR should be performed either with fewer cycles
n the ﬁrst non–allele-speciﬁc PCR or with fewer
ycles for the allele-speciﬁc second PCR. The use of
ore template DNA is not advisable because it in-
reases the background signal, whereas the use of less
emplate DNA decreases the sensitivity (data not
hown).
ensitivity of the HA-1 Nested PCR
To determine the sensitivity of the developed
A-1 allele–speciﬁc nested PCR, different numbers
igure 1. Scheme of part of the HA-1–encoding locus, indicating
rimer positions used for the development of the HA-1 allele–
peciﬁc nested PCR.
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Detection of HA-1 Microchimerism
Bf EBV-BLCL cells homozygous for HA-1H were
itrated in EBV-BLCL cells homozygous for HA-1R.
he serial dilution series consisted of a ratio of HA-1H
o HA-1R from 1:101 to 1:108. After DNA isolation of
hese cell mixtures, PCR fragments could consistently
e obtained from 750 ng of genomic DNA isolated
rom the cell batch with a ratio of HA-1H to HA-1R of
:104 (Figure 2). The 105 dilution sample showed a
CR fragment in approximately 50% of the PCR
eactions performed. Thus, analysis of triplicates of
ach sample is sufﬁcient to detect 1 HA-1H cell in 105
A-1R cells.
etection of HA-1 Microchimerism in Blood
amples from mHag-Immunized Individuals
Two sources of samples with assumed microchi-
erism were tested. One sample source was derived
rom an HLA-A2 HA-1R multiparous healthy female
onor who delivered 1 HLA-A2 HA-1R and 1 HLA-A2
A-1H child. Using the developed HA-1 allele–spe-
iﬁc nested PCR, we could detect the HA-1H–encod-
ng gene in DNA isolated from PBMCs from the
other, most likely derived from the second child.
he other sample source was derived from renal allo-
raft recipients who displayed T-cell reactivity against
he mismatched mHag HA-1 [7]. The recipients were
igure 2. Sensitivity determination of the HA-1 nested PCR. A,
IIH as the forward primer in the second PCR step. B, FIIR as the
orward primer in the second PCR step. M indicates marker; lane 1,
o template control; lanes 2 to 9, PCR results of serial dilutions of
ells homozygous for HA-1H diluted in cells homozygous for
A-1R in a ratio of 1:10 to 1:108; lane 10, homozygous HA-1H
ontrol sample; lane 11, homozygous HA-1R control sample.
igure 3. Analysis of a clinical sample for the presence of HA-1 m
idney transplantation patient receiving an HA-1H kidney graft. A, F
sing FIIR as the forward primer in the second PCR step. Lanes 1
n a ratio of 1:10 to 1:108; lane 9, homozygous H control sample; lan
ell fraction; lane 13, DC2 cell fraction; lane 14, B-cell fraction; lan
ontrol of the second PCR; M, marker.
B&MTyped HA-1R and received an HLA-matched HA-1H
idney graft. T cells, B cells, dendritic cells, and
onocytes were isolated from PBMCs of these indi-
iduals, and the presence of HA-1H microchimerism
as analyzed by using the nested PCR. In the PBMCs
f renal allografted patients, HA-1H microchimerism
as observed in the T-cell fraction, the dendritic cell
opulation, or both (Figure 3).
ISCUSSION
We developed a nested PCR for the determina-
ion of mHag HA-1 microchimerism. With this newly
eveloped nested PCR, we are able to consistently
etect 1 HA-1H cell in 104 HA-1R cells without losing
peciﬁcity. To reach a 10-fold higher sensitivity, ie, 1
A-1H cell in 105 HA-1R cells, triplicates of the same
ample need to be performed. The amount of DNA
er human diploid cell is 6 pg, which translates into
25 000 copies of the desired template DNA when
50 ng is used per reaction. Thus, the sensitivity of the
eveloped nested PCR reaction approximates the
umber that it is theoretically possible to detect. This
utomatically implies that the detection limit of the
ested PCR is 1 HA-1H cell in 105 HA-1R cells. The
mount of template DNA that can be used in the
eaction is the limiting factor because an increase in
emplate DNA, with more than 750 ng per reaction,
ecreases the speciﬁcity. The lack of PCR product in
igher dilutions, 1:106 to 1:108, underlines the speci-
city of the developed nested PCR.
Microchimerism is deﬁned as the presence of low
umbers of foreign cells in an individual. It occurs as
result of pregnancy wherein, in mutual directions,
ells ﬂow from the fetus to the mother, from the
other to the fetus, or both. Blood transfusion, solid
rgan transplantation, and stem cell transplantation
lso lead to the establishment of microchimerism.
pplying the developed nested PCR, we showed the
resence of mHag HA-1 microchimerism in multip-
rous healthy women and in renal allografts recipients.
Nested PCR and real-time quantitative PCR, both
imerism. Nested PCR results of a sample derived from an HA-1R
he forward primer in the second PCR step. B, Positive control PCR
icate PCR results of serial dilution of HA-1H cells in HA-1R cells
mozygous R control sample; lane 11, T-cell fraction; lane 12, DC1
nd 16, no-template control of the ﬁrst PCR; lane 17, no-templateicroch
IIH as t
to 8 ind
e 10, ho
es 15 a347
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3ighly sensitive methods, are used to detect mixed
himerism [8]. One example is the use of Y chromo-
ome–speciﬁc sequences for the detection of remain-
ng male cells after sex-mismatched allogeneic stem
ell transplantation involving a male patient and a
emale donor [9]. Naturally, analyses of microchimer-
sm should be performed longitudinally. Especially in
ransplantation settings, determination of pretrans-
lantation microchimeric levels in both the donor and
he patient is needed. These values are especially rel-
vant in female individuals: HA-1 microchimerism
as demonstrated in 2 of our cases. Both these cases
ere female renal allografted patients with a history of
arity (also see Verdijk et al. [5]).
In stem cell transplantation settings, detection of
ecreasing donor chimerism is used as a marker in-
icative of relapse [8]. Another relevant area for de-
ermining mHag HA-1 microchimerism is in patients
ho undergo stem cell–based mHag HA-1–speciﬁc
mmunotherapy for hematologic and nonhematologic
alignancies [10]. The time of the mHag immuno-
herapeutic intervention in the HA-1–mismatched pa-
ient/donor pairs is important. Namely, signiﬁcant
evels of the patient’s remaining hematopoietic cells
an cause graft-versus-host disease [11]. The exact
evel of mixed chimeric status in the mHag immuno-
herapeutic phase I/II trials is as yet unknown. It is
nteresting to note that in a murine model of donor
ymphocyte infusion, the administration of donor
ymphocyte infusion mixed chimeras showed a pow-
rful graft-versus-leukemia effect when compared
ith the administration of donor lymphocyte infusion
ull chimeras [12].
In conclusion, we have developed a highly sensi-
ive allele-speciﬁc nested PCR that allows detection of
Hag HA-1 microchimerism. This tool will aid in
creening transplantation patients for the risk of re-
apse and in the timing of HA-1 immunotherapy.
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